 |
 |
November
22, 2005 |
 |
|
 |
Volume
VI, Issue 100 |
 |
|
Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
To
OTC Journal Members:
 |
Comments
in the BLOG |
 |
Today's edition marks Number 100
for 2005. A very busy year. So far, the first half was good, the second
half terrible. It's going to get better. We are due.
There is a BLOG entry on new
idea UpSnap (OTC BB: UPSN). As I stated in the original presentation,
UPSN
is setting up to be Mr. Toad's wild ride. On the first day of trading it's
range was $2.45 to $3.10. That's no different than a stock trading between
$24.50 and $31.10 on the same day. On Monday morning I was able to compute
the perfect entry level at about $2.40, and a stop loss level at $2.30.
It the stock trades much below $2.30, just sell it and take your loss.
There is a new BLOG with a more detailed explanation.
To use the BLOG, simply go
to the home page at www.otcjournal.com
- the BLOG will scroll down automatically on the right side of your
screen. The most current journal entries appear in the middle of your screen.
Check back frequently for updates particularly when stocks are moving to
overbought or oversold levels or in volatile markets. Your questions and
postings do not automatically appear, so don't bother posting the same
question multiple times. I personally go through to moderate and respond
to every question.
 |
NetWork (OTC
BB: NTWK) and Health Sciences (OTC BB: HESG) Lead Us to the Holiday |
|
NTWK and HESG were
both out with news releases this Tuesday morning as we roll into the Thanksgiving
holiday. These two turkeys appear to have escaped the Thanksgiving table
this year, and should spend another year growing nicely. Paying attention
to unfolding events when most investors are out of touch can be very profitable.
It gives you a competitive edge.
HESG published a lengthy news
release which gives us some insight as to where they stand on sales of
SHUGR.
The news release warns us that revenues for the September quarter for the
company were minimal, but sales of SHUGR appear to be gaining some
real traction. Here are the highlights:
-
DNP, their food distribution
manufacturer, has agreed to guarantee HESG $2 million in SHUGR
sales in 2006. DNP sold 2 million lbs of Vitamin C in 2004. DNP's job is
to get food and beverage manufacturers to include SHUGR as an ingredient.
This is where I believe the really big revenues could come down the road.
-
GNC, Vitamin Shoppe, Meijer, ValueDrug
and drugstore.com are now all carrying the product. The company has recently
received PO's from GNC and the Vitamin Shoppe. According to HESG,
the product is moving from testing phase to full distribution and featured
shelf space at the nationwide chains.
-
The company is close to an exclusive
deal with a Japanese distributor with 50,000 retail doors in Japan. The
deal would require a minimum of $1.1 million in PO's in 2006, tripling
every year thereafter.
-
Despite not being included in today's
press release, don't forget SHUGR will make its debut on QVC network
in January. It will be sold in a grouping of a dozen cookies baked with
SHUGR,
a cookbook, and a container of the product.
The technical picture on the stock continues
to improve slightly. The stock appears to have made its October low, and
is trying to rebound. As the company announces definitive sales events,
the stock will probably firm. I would like to see it back at $.75 ASAP-
I know that is a comfort level for many subscribers as that is the level
there were a lot of buyers in the stock. It's trying to work higher today.
NetWork Installation also
delivered a powerful update today. The company disclosed Q3 numbers, and
they basically a non-event because they were not reflective of the current
businesses of the company.
While NTWK delivered $1.1
million in revs in the quarter, a follow up press release disclosed their
current backlog at $16 million in contracts, which are being
worked on at this very moment.
Kelley Technologies was acquired
on Sep 22, so there were only 8 days of Kelley's performance in the Q3
numbers. The Spectrum acquisition closed on November 1, one month into
Q4. Therefore, the Q4 numbers will include 100% of Kelley's performance,
and 66% of Spectrum's performance. We won't get the full picture until
Q1 numbers in '06.
The bottom line is $16 million in
current contracts which are ongoing. I don't have a good feel for where
it puts the company profit wise, but I know the pub co expenses are now
split amongst a much higher revenue number, which is a major positive for
shareholders.
It will be a whole new world for
NTWK
in 2006. If interest returns to microcap stocks in the telecom/internet
infrastructure sector, this one should garner a lot of attention. Investors
bet on Jeffery's Hultman's roll up strategies with Pac Tel and made a fortune.
It would be foolhardy to be against him now. Look for a whole new face
on this company.
The chart of NWKI is pretty
schizophrenic. The only conclusion I can draw at this time is "buy the
pullbacks". Each time the stock has moved to oversold levels it has bounced,
then headed back. Follow the bouncing ball, and buy at the bounce level.
 |
Subscribe |
 |
Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription.
Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.
To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best
way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable
email newsletter delivery.
Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.
|
|
| The OTCjournal.com Newsletter is
an independent electronic publication committed to providing our readers
with factual information on selected publicly traded companies. All
companies are chosen on the basis of certain financial analysis and other
pertinent criteria with a view toward maximizing the upside potential
for investors while minimizing the downside risk, whenever possible.
Moreover, as detailed below, this publication accepts compensation from
certain of the companies which it features. Likewise, this newsletter
is owned by MarketByte, LLC. To the degrees enumerated herein,
this newsletter should not be regarded as an independent publication.
Go
Here to view our compensation on every company we have ever covered,
or visit the following web address: http://www.otcjournal.com/disclaimer.html
for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html
for Trading Alerts. Health Sciences Group, Inc has paid MarketByte LLC
as fee of $25,000 in cash, 200,000 newly issued restricted shares, and
200,000 warrants convertible at $.88 for ongoing coverage of the company.
MarketByte LLC has been paid of fee of $25,000 and 500,000 post split newly
issued restricted shares by NetWork Installation for coverage of the company.
The aforementioned restricted shares are now eligible to be free trading
due to an effective registration statement and maturing under Rule 144.
All statements and expressions are
the sole opinions of the editors and are subject to change without notice.
A profile, description, or other mention of a company in the newsletter
is neither an offer nor solicitation to buy or sell any securities
mentioned. While we believe all sources of information to be factual and
reliable, in no way do we represent or guarantee the accuracy thereof,
nor the statements made herein.
From time to time MarketByte LLC
sells shares in the open market it receives as compensation for coverage
of client companies. Since the shares are received as compensation for
services as previously disclosed, and not for investment purposes, the
editors do not view the sale of the shares as contradictory to any advice
delivered in the content. This should be viewed as a conflict of interest
by shareholders or prospective shareholders of the client companies.
The editor, members of the editor's
family, and/or entities with which they are affiliated aside from MarketBtye
LLC itself, are forbidden by company policy to own, buy, sell or otherwise
trade stock for their own benefit in the companies who appear in the publication
unless specifically disclosed in the newsletter. Some of the companies
featured in the OTC Journal pay a cash ESP fee to an affiliated technology
company ranging from $2,000 to $5,000 per month for internet related technology
services.
The Trustee of the MarketByte LLC
Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested
approximately $140,0000 in Dutchess Private Equities II LP (“the Dutchess
Limited Partnership”), a limited partnership in which the MarketByte Pension
Plan is a limited partner. No one associated with the MarketByte
Pension Plan has any knowledge, information, or control as to any past,
present, or future investment activities of the Dutchess Limited Partnership.
The Dutchess Limited Partnership is one of two hedge funds managed by Dutchess
Advisors. Dutchess Advisors periodically refers companies to MarketByte
LLC for possible coverage by one of the MarketByte LLC publications, which
publications include The OTCJournal.com Newsletter. Dutchess Advisors
may or may not own shares in the companies that it so refers to MarketByte.
MarketByte has no information (outside of information readily accessible
to the general public such as SEC filings) as to whether Dutchess Advisors
owns any shares in the companies that it refers to MarketByte LLC.
The above relationships should be viewed as a potential and/or actual conflict
of interest by shareholders and prospective shareholders of MarketByte
LLC client companies.
The profiles, critiques, and other
editorial content of the OTCjournal.com may contain statements that appear
foward relating to the expected capabilities of the companies mentioned
herein.
THE READER SHOULD VERIFY ALL CLAIMS
AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED.
INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE
OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT
LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY
WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCjournal.com.
We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or
the National Association of Securities Dealers ("NASD") at http://www.nasd.com.
We also strongly recommend that you read the SEC advisory to investors
concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Disclaimer ID:$subst('Recip.userid') Readers can review all public filings
by companies at the SEC's EDGAR page. The NASD has published information
on how to invest carefully at its web site. MarketByte LLC's mailing
address is 3525 Del Mar Heights Rd #334, San Diego, CA 92130.
You
can unsubscribe from this list at any time by Clicking
Here and HITTING SEND. If you are having difficulty removing
yourself or wish to change your address please go to http://listserv.otcjournal.com/opt.cgi?. |
|
|
|
Click Here to View the OTC Journal Disclosure
|
|
To subscribe to our newsletter, please enter your email address below.
Quotes are delayed 20 minutes.

|